Captor Therapeutics S.A. (CTX) — Capital Reinvestment Ratio
Latest as of March 2025:
0.00x
Captor Therapeutics S.A. (CTX) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow (zł23.06 Million) in capital expenditures (zł83.00K). See how much free cash does Captor Therapeutics S.A. generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
zł23.06 Million
PLN
Capital Expenditures
zł83.00K
PLN
Data as of
Mar 2025
Most recent filing
Captor Therapeutics S.A. Capital Reinvestment Ratio (2019–2019)
This chart tracks Captor Therapeutics S.A.'s Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Captor Therapeutics S.A. (2019–2019)
Year-by-year Capital Reinvestment Ratio for Captor Therapeutics S.A. from 2019 to 2019. For live market cap and broader valuation context, see CTX company net worth.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.05x | zł4.39 Million | zł229.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow